Skip to main content

Rohan Vashi, PharmD, MSc

Authored Items
Epkinly Receives Accelerated Approval for Treatment of Follicular Lymphoma After ≥2 Lines of Systemic Therapy
Rohan Vashi, PharmD, MSc
November 2024 Vol 17, Payers' Guide to FDA Updates in In-Depth Treatment Profile, FDA Approvals, Bispecific Antibodies
Bispecific Antibody Columvi Offering Option in Diffuse Large B-cell Lymphoma Treatment
Rohan Vashi, PharmD, MSc
November 2024 Vol 17, Payers' Guide to FDA Updates in In-Depth Treatment Profile, A Payer Perspective, FDA Approvals, Bispecific Antibodies
Ongoing Analyses and Recent Data for Talvey in Multiple Myeloma
Rohan Vashi, PharmD, MSc
November 2024 Vol 17, Payers' Guide to FDA Updates in In-Depth Treatment Profile, Multiple Myeloma, Oncology, Bispecific Antibodies
Imdelltra Approved for Treatment of Extensive-Stage Small Cell Lung Cancer on or Following Disease Progression While on Platinum-Based Chemotherapies
Rohan Vashi, PharmD, MSc
November 2024 Vol 17, Payers' Guide to FDA Updates in In-Depth Treatment Profile
Last modified: November 26, 2024